R&D FOR REPURPOSING FX06, A HOST-DIRECTED THERAPY, FOR TREATMENT OF SEVERE DISEASE IN PATIENTS WITH SUDAN VIRUS DISEASE (SVD) OR OTHER FILOVIRUSES AOI #22 REBOOT
$748,039
| Recipient | PARTNER THERAPEUTICS, INC. UEI J33MSDBJZMC6 |
|---|---|
| Award ID | 75A50123C00064 |
| Award amount | $748,039 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN15 |
| Start date | Sep 25, 2023 |
| End date | Mar 25, 2025 |
| Place of performance | LEXINGTON, MA |
| Record updated | Jun 1, 2026 |
View the official award record
More awards won by PARTNER THERAPEUTICS, INC.
LEUKINE 250MCG/VIL INJ
Department of Health and Human Services · $59,026,989 · Jul 25, 2022
LEUKINE 250MCG VIL INJ (5PKG)
Department of Health and Human Services · $22,199,262 · Sep 26, 2023
PARTNER THERAPEUTICS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO CONFIRM LEUKINE SAFETY IN SEPSIS PATIENTS, INFORM OPTIMAL LEUKINE DOSING, EXPLORE LEUKINE EFFICACY, AS WELL AS ADVANCE DEVELOPMENT OF MONOCYTE HUMAN LEUKOCYTE ANTIGEN-DR (MHLA-DR) AS
Department of Health and Human Services · $12,990,717 · Sep 30, 2024
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $4,413,920 · Aug 15, 2023
PARTNER THERAPEUTICS, INC.: .: BARDA DRIVE : RESEARCH AND DEVELOPMENT OF DIAGNOSTIC TESTS FOR PATIENTS WITH SEPSIS AND IMMUNOPARALYSIS
Department of Health and Human Services · $748,912 · Sep 2, 2021
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids